146 related articles for article (PubMed ID: 38142548)
1. Prognostic analysis of pulmonary hypertension with lung parenchymal lesion: Comparison of mortality with and without connective tissue disease.
Suzuki Y; Nagaoka T; Terayama Y; Nagata Y; Yoshida T; Tsutsumi T; Kuriyama S; Matsushita M; Joki Y; Takasu K; Konishi H; Takahashi K
Respir Investig; 2024 Jan; 62(1):167-175. PubMed ID: 38142548
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment.
Cansu DÜ; Korkmaz C
Clin Rheumatol; 2023 Oct; 42(10):2601-2610. PubMed ID: 36396789
[TBL] [Abstract][Full Text] [Related]
3. Early combination of pulmonary vasodilators prevents chronic kidney disease progression in connective tissue disease-associated pulmonary hypertension.
Hanaoka H; Ishigaki S; Takei H; Hiramoto K; Saito S; Kondo Y; Kikuchi J; Kaneko Y; Takeuchi T
Int J Rheum Dis; 2021 Nov; 24(11):1419-1426. PubMed ID: 34626090
[TBL] [Abstract][Full Text] [Related]
4. Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study.
Takahashi K; Taniguchi H; Ando M; Sakamoto K; Kondoh Y; Watanabe N; Kimura T; Kataoka K; Suzuki A; Ito S; Hasegawa Y
BMC Pulm Med; 2016 Apr; 16(1):55. PubMed ID: 27094018
[TBL] [Abstract][Full Text] [Related]
5. Survival and prognostic factors in patients with connective tissue disease-associated pulmonary hypertension diagnosed by echocardiography: results from a Korean nationwide registry.
Kang KY; Jeon CH; Choi SJ; Yoon BY; Choi CB; Lee CH; Suh CH; Lee CW; Cho CS; Nam EJ; Koh EM; Kim HY; Choi HJ; Kim HA; Jun JB; Lee J; Kim J; Ji JD; Min JK; Kim KJ; Shin K; So MW; Kwon SR; Kim SK; Nah SS; Kwok SK; Lee SK; Lee SW; Park SH; Park W; Park YB; Lee YH; Lee SS; Yoo DH
Int J Rheum Dis; 2017 Sep; 20(9):1227-1236. PubMed ID: 26214170
[TBL] [Abstract][Full Text] [Related]
6. Multi-institutional retrospective cohort study of patients with severe pulmonary hypertension associated with respiratory diseases.
Tanabe N; Taniguchi H; Tsujino I; Sakamaki F; Emoto N; Kimura H; Takamura K; Hanaoka M; Nishimura M; Tatsumi K;
Respirology; 2015 Jul; 20(5):805-12. PubMed ID: 25828844
[TBL] [Abstract][Full Text] [Related]
7. Management of interstitial lung disease associated with connective tissue disease.
Mathai SC; Danoff SK
BMJ; 2016 Feb; 352():h6819. PubMed ID: 26912511
[TBL] [Abstract][Full Text] [Related]
8. Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis.
Enomoto N; Oyama Y; Enomoto Y; Yasui H; Karayama M; Kono M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
Chron Respir Dis; 2019; 16():1479972318809476. PubMed ID: 30380910
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary infections following immunosuppressive treatments during hospitalization worsen the short-term vital prognosis for patients with connective tissue disease-associated interstitial pneumonia.
Tanaka M; Koike R; Sakai R; Saito K; Hirata S; Nagasawa H; Kameda H; Hara M; Kawaguchi Y; Tohma S; Takasaki Y; Dohi M; Nishioka Y; Yasuda S; Miyazaki Y; Kaneko Y; Nanki T; Watanabe K; Yamazaki H; Miyasaka N; Harigai M
Mod Rheumatol; 2015 Jul; 25(4):609-14. PubMed ID: 25496409
[TBL] [Abstract][Full Text] [Related]
10. Treatment of pulmonary hypertension in patients with connective tissue disease and interstitial lung disease.
Mittoo S; Jacob T; Craig A; Bshouty Z
Can Respir J; 2010; 17(6):282-6. PubMed ID: 21165350
[TBL] [Abstract][Full Text] [Related]
11. The short-term role of corticosteroid therapy for pulmonary arterial hypertension associated with connective tissue diseases: report of five cases and a literature review.
Kato M; Kataoka H; Odani T; Fujieda Y; Otomo K; Oku K; Horita T; Yasuda S; Atsumi T; Ohira H; Tsujino I; Nishimura M; Koike T
Lupus; 2011 Oct; 20(10):1047-56. PubMed ID: 21676917
[TBL] [Abstract][Full Text] [Related]
12. [Pulmonary hypertension in patients with connective tissue diseases].
Yoshida S; Katayama M
Nihon Rinsho; 2001 Jun; 59(6):1164-7. PubMed ID: 11411130
[TBL] [Abstract][Full Text] [Related]
13. Diversity of hemodynamic types in connective tissue disease associated pulmonary hypertension: more than a subgroup of pulmonary arterial hypertension.
Dong X; Shi Y; Xia Y; Zhang X; Qian J; Zhao J; Peng J; Wang Q; Weng L; Li M; Du B; Zeng X
BMC Pulm Med; 2022 Aug; 22(1):295. PubMed ID: 35909128
[TBL] [Abstract][Full Text] [Related]
14. Retrospective cohort study of pulmonary arterial hypertension associated with connective tissue disease effect on patients' prognosis.
Huang J; An Q; Shi H; Li C; Zhang W; Wang L
Clin Rheumatol; 2023 Nov; 42(11):3131-3142. PubMed ID: 37382842
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Treatment Response in Idiopathic and Connective Tissue Disease-associated Pulmonary Arterial Hypertension.
Rhee RL; Gabler NB; Sangani S; Praestgaard A; Merkel PA; Kawut SM
Am J Respir Crit Care Med; 2015 Nov; 192(9):1111-7. PubMed ID: 26291092
[TBL] [Abstract][Full Text] [Related]
16. Predictors of Favorable Responses to Immunosuppressive Treatment in Pulmonary Arterial Hypertension Associated With Connective Tissue Disease.
Yasuoka H; Shirai Y; Tamura Y; Takeuchi T; Kuwana M
Circ J; 2018 Jan; 82(2):546-554. PubMed ID: 28904255
[TBL] [Abstract][Full Text] [Related]
17. [Management of borderline pulmonary arterial hypertension associated with connective tissue diseases].
Yoshifuji H; Kinoshita H
Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(6):454-61. PubMed ID: 25748129
[TBL] [Abstract][Full Text] [Related]
18. Significance of pulmonary arterial pressure as a prognostic indicator in lung-dominant connective tissue disease.
Suzuki A; Taniguchi H; Watanabe N; Kondoh Y; Kimura T; Kataoka K; Matsuda T; Yokoyama T; Sakamoto K; Nishiyama O; Hasegawa Y
PLoS One; 2014; 9(9):e108339. PubMed ID: 25268705
[TBL] [Abstract][Full Text] [Related]
19. Serum uric acid is associated with disease severity and may predict clinical outcome in patients of pulmonary arterial hypertension secondary to connective tissue disease in Chinese: a single-center retrospective study.
Wang J; Wang Y; Li X; Huang Y; Sun X; Wang Q; Zhang M
BMC Pulm Med; 2020 Oct; 20(1):272. PubMed ID: 33076877
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological management of connective tissue disease-associated pulmonary arterial hypertension.
Kularatne M; Boucly A; Savale L; Solinas S; Cheron C; Roche A; Jevnikar M; Jaïs X; Montani D; Humbert M; Sitbon O
Expert Opin Pharmacother; 2023; 24(18):2101-2115. PubMed ID: 37869785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
